FILTER
Refine your search with the following facets to narrow down your results.
- phase III studies 27
- food 26
- regulatory approval 22
- reductions 19
- diagnostics 17
- oncology 17
- Switzerland 16
- medicine 16
- hypertension 15
- antibodies 14
- Japan 12
- Sandoz 12
- high blood pressure 12
- inhibitors 12
- chronic myeloid leukemia 11
- Germany 10
- cell cultures 10
- chemotherapy 10
- meningococcal disease 9
- multiple sclerosis 9
- pressure 9
- Ablynx 8
- MorphoSys 8
- services 8
- immunogenicity 7
- inflammation 7
- lung cancer 7
- pandemic influenza 7
- renin inhibitors 7
- biopharmaceuticals 6
- drug development 6
- infectious diseases 6
- proteins 6
- pulmonary diseases 6
- surgery 6
- tumors 6
- validation 6
- Alnylam 5
- Bio-Medical Research 5
- Iceland 5
- USA 5
- blood cancer 5
- cancer 5
- flow 5
- genes 5
- growth factors 5
- inflammatory disease 5
- pain 5
- scale-up 5
- seasonal influenza 5
- AGES 4
- Antisoma 4
- Chiron 4
- Spain 4
- arthritis 4
- bacteria 4
- biologics 4
- biology 4
- breast cancer 4
- cardiovascular diseases 4
- chronic obstructive pulmonary disease 4
- dosing 4
- gastrointestinal stromal tumor 4
- generics 4
- interferon 4
- laboratories 4
- malaria 4
- myocardial infarction 4
- pancreatic cancer 4
- phosphate 4
- research collaborations 4
- therapeutic antibodies 4
- tuberous sclerosis 4
- tumor growth 4
- GlaxoSmithKline 3
- Intercell 3
- Life Science 3
- Nestlé 3
- Norway 3
- RNA interference 3
- Schering 3
- Singapore 3
- acute myocardial infarction 3
- anti-infectives 3
- antibiotics 3
- antigens 3
- asthma 3
- bacterial meningitis 3
- biomarkers 3
- calcium 3
- central nervous system 3
- drug discovery 3
- gastrointestinal cancer 3
- genomes 3
- gout 3
- Novartis International AG 236
- U. S. Food and Drug Administration (FDA) 14
- Ablynx nv 8
- MorphoSys AG 8
- Alcon Inc. 5
- Alnylam Pharmaceuticals, Inc. 5
- European Medicines Agency (EMA) 5
- Novartis Pharma AG 5
- Sandoz GmbH 5
- Antisoma plc 4
- GlaxoSmithKline plc (GSK) 4
- Sandoz International GmbH 4
- Bayer Schering Pharma AG 3
- Chiron Corporation 3
- Citigate Dewe Rogerson 3
- Intercell AG 3
- Novartis Institutes for BioMedical Research (NIBR) 3
- Speedel 3
- Crucell N.V. 2
- EBEWE Pharma Ges.m.b.H Nfg.KG 2
- Eli Lilly and Company 2
- Evotec SE 2
- Galapagos NV 2
- Heptares Therapeutics Ltd 2
- Monsoon Communications 2
- Nestlé S.A. 2
- NeuTec Pharma plc 2
- Orion Corporation 2
- Paratek Pharmaceuticals, Inc. 2
- Phosphagenics Limited 2
- ProStrakan Group plc 2
- Sosei Co. Ltd. 2
- Swissmedic Schweizerisches Heilmittelinstitut 2
- The Scripps Research Institute (TSRI) 2
- Vectura Group plc 2
- Vernalis (R & D) Limited 2
- Wyeth 2
- Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. 2
- sanofi-aventis Groupe 2
- AlphaVax, Inc. 1
- Arakis Ltd 1
- AstraZeneca PLC 1
- BASF SE 1
- BTG plc 1
- Bar-Ilan University 1
- BioGaia AB 1
- Bristol-Myers Squibb Co. 1
- Broad Institute of MIT and Harvard 1
- CSL Limited 1
- Calypso Biotech SA 1
- Cancer Research Technology Limited (CRT) 1
- Capital MS&L Limited 1
- Cellzome AG 1
- College Hill 1
- Consejo Superior De Investigaciones Científias (CSIC) 1
- Corthera Inc. 1
- CureVac AG 1
- Debiopharm S.A. 1
- Eon Labs 1
- Europäische Kommission 1
- F. Hoffmann-La Roche AG 1
- Fraunhofer-Institut für Zelltherapie und Immunologie (IZI) 1
- Fujirebio Europe N.V. 1
- Gen-Probe Incorporated 1
- Genedata AG 1
- Google Inc. 1
- H. Lundbeck A/S 1
- HBM Healthcare Investments AG 1
- Halsin Partners Ltd. 1
- Harvard University 1
- Hexal AG 1
- Human Genome Sciences 1
- ImmunoGen, Inc. 1
- Imperial Innovations Group plc 1
- Incyte Corporation 1
- Janssen Pharmaceutica NV 1
- Karolinska Institutet 1
- King's College London 1
- Laboratorios Farmaceúticos ROVI 1
- Lonza Group Ltd 1
- M: Communications 1
- MC Services AG 1
- Massachusetts Institute of Technology 1
- Max-Planck-Institut für molekulare Biomedizin 1
- Merck & Co., Inc. 1
- Merck KGaA 1
- MilliporeSigma 1
- National Institute of Allergy and Infectious Diseases (NIAID) 1
- National Institutes of Health (NIH) 1
- Nektar Therapeutics 1
- Novartis Animal Health Inc. 1
- Novartis Institute for Tropical Diseases (NITD) 1
- Novartis Research Foundation 1
- Nuevolution A/S 1
- Pfizer Inc. 1
- Poseida Therapeutics, Inc. 1
- Protez Phamaceuticals 1
- Psynova Neurotech Ltd 1
- Research and Markets 1
- Sankyo Co., Ltd 1
- Sankyo Lifetech Company, Limited 1
- Santhera Pharmaceuticals AG 1
- Schering-Plough Corporation 1
- SeBo GmbH 1
- Servier 1
- Singapore Economic Development Board 1
- Spinifex Pharmaceuticals 1
- State Food and Drug Administration (SFDA) 1
- Synosia Therapeutics 1
- Takeda Pharmaceutical Company Limited 1
- Tecan Group Ltd 1
- The Wellcome Trust 1
- U.S. Department of Health and Human Services (HHS) 1
- UCB GmbH 1
- UCB S.A. 1
- University of Cambridge 1
- University of Leicester 1
- University of Manchester 1
- University of Pennsylvania 1
- Vanda Pharmaceuticals 1
- WILEY-VCH GmbH 1
- Zentralinstitut für Seelische Gesundheit 1
- deCODE genetics 1
242 Current news of Novartis
FILTERS
Refine your search with the following facets to narrow down your results.
- phase III studies 27
- food 26
- regulatory approval 22
- reductions 19
- diagnostics 17
- oncology 17
- Switzerland 16
- medicine 16
- hypertension 15
- antibodies 14
- Japan 12
- Sandoz 12
- high blood pressure 12
- inhibitors 12
- chronic myeloid leukemia 11
- Germany 10
- cell cultures 10
- chemotherapy 10
- meningococcal disease 9
- multiple sclerosis 9
- pressure 9
- Ablynx 8
- MorphoSys 8
- services 8
- immunogenicity 7
- inflammation 7
- lung cancer 7
- pandemic influenza 7
- renin inhibitors 7
- biopharmaceuticals 6
- drug development 6
- infectious diseases 6
- proteins 6
- pulmonary diseases 6
- surgery 6
- tumors 6
- validation 6
- Alnylam 5
- Bio-Medical Research 5
- Iceland 5
- USA 5
- blood cancer 5
- cancer 5
- flow 5
- genes 5
- growth factors 5
- inflammatory disease 5
- pain 5
- scale-up 5
- seasonal influenza 5
- AGES 4
- Antisoma 4
- Chiron 4
- Spain 4
- arthritis 4
- bacteria 4
- biologics 4
- biology 4
- breast cancer 4
- cardiovascular diseases 4
- chronic obstructive pulmonary disease 4
- dosing 4
- gastrointestinal stromal tumor 4
- generics 4
- interferon 4
- laboratories 4
- malaria 4
- myocardial infarction 4
- pancreatic cancer 4
- phosphate 4
- research collaborations 4
- therapeutic antibodies 4
- tuberous sclerosis 4
- tumor growth 4
- GlaxoSmithKline 3
- Intercell 3
- Life Science 3
- Nestlé 3
- Norway 3
- RNA interference 3
- Schering 3
- Singapore 3
- acute myocardial infarction 3
- anti-infectives 3
- antibiotics 3
- antigens 3
- asthma 3
- bacterial meningitis 3
- biomarkers 3
- calcium 3
- central nervous system 3
- drug discovery 3
- gastrointestinal cancer 3
- genomes 3
- gout 3
- Novartis International AG 236
- U. S. Food and Drug Administration (FDA) 14
- Ablynx nv 8
- MorphoSys AG 8
- Alcon Inc. 5
- Alnylam Pharmaceuticals, Inc. 5
- European Medicines Agency (EMA) 5
- Novartis Pharma AG 5
- Sandoz GmbH 5
- Antisoma plc 4
- GlaxoSmithKline plc (GSK) 4
- Sandoz International GmbH 4
- Bayer Schering Pharma AG 3
- Chiron Corporation 3
- Citigate Dewe Rogerson 3
- Intercell AG 3
- Novartis Institutes for BioMedical Research (NIBR) 3
- Speedel 3
- Crucell N.V. 2
- EBEWE Pharma Ges.m.b.H Nfg.KG 2
- Eli Lilly and Company 2
- Evotec SE 2
- Galapagos NV 2
- Heptares Therapeutics Ltd 2
- Monsoon Communications 2
- Nestlé S.A. 2
- NeuTec Pharma plc 2
- Orion Corporation 2
- Paratek Pharmaceuticals, Inc. 2
- Phosphagenics Limited 2
- ProStrakan Group plc 2
- Sosei Co. Ltd. 2
- Swissmedic Schweizerisches Heilmittelinstitut 2
- The Scripps Research Institute (TSRI) 2
- Vectura Group plc 2
- Vernalis (R & D) Limited 2
- Wyeth 2
- Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. 2
- sanofi-aventis Groupe 2
- AlphaVax, Inc. 1
- Arakis Ltd 1
- AstraZeneca PLC 1
- BASF SE 1
- BTG plc 1
- Bar-Ilan University 1
- BioGaia AB 1
- Bristol-Myers Squibb Co. 1
- Broad Institute of MIT and Harvard 1
- CSL Limited 1
- Calypso Biotech SA 1
- Cancer Research Technology Limited (CRT) 1
- Capital MS&L Limited 1
- Cellzome AG 1
- College Hill 1
- Consejo Superior De Investigaciones Científias (CSIC) 1
- Corthera Inc. 1
- CureVac AG 1
- Debiopharm S.A. 1
- Eon Labs 1
- Europäische Kommission 1
- F. Hoffmann-La Roche AG 1
- Fraunhofer-Institut für Zelltherapie und Immunologie (IZI) 1
- Fujirebio Europe N.V. 1
- Gen-Probe Incorporated 1
- Genedata AG 1
- Google Inc. 1
- H. Lundbeck A/S 1
- HBM Healthcare Investments AG 1
- Halsin Partners Ltd. 1
- Harvard University 1
- Hexal AG 1
- Human Genome Sciences 1
- ImmunoGen, Inc. 1
- Imperial Innovations Group plc 1
- Incyte Corporation 1
- Janssen Pharmaceutica NV 1
- Karolinska Institutet 1
- King's College London 1
- Laboratorios Farmaceúticos ROVI 1
- Lonza Group Ltd 1
- M: Communications 1
- MC Services AG 1
- Massachusetts Institute of Technology 1
- Max-Planck-Institut für molekulare Biomedizin 1
- Merck & Co., Inc. 1
- Merck KGaA 1
- MilliporeSigma 1
- National Institute of Allergy and Infectious Diseases (NIAID) 1
- National Institutes of Health (NIH) 1
- Nektar Therapeutics 1
- Novartis Animal Health Inc. 1
- Novartis Institute for Tropical Diseases (NITD) 1
- Novartis Research Foundation 1
- Nuevolution A/S 1
- Pfizer Inc. 1
- Poseida Therapeutics, Inc. 1
- Protez Phamaceuticals 1
- Psynova Neurotech Ltd 1
- Research and Markets 1
- Sankyo Co., Ltd 1
- Sankyo Lifetech Company, Limited 1
- Santhera Pharmaceuticals AG 1
- Schering-Plough Corporation 1
- SeBo GmbH 1
- Servier 1
- Singapore Economic Development Board 1
- Spinifex Pharmaceuticals 1
- State Food and Drug Administration (SFDA) 1
- Synosia Therapeutics 1
- Takeda Pharmaceutical Company Limited 1
- Tecan Group Ltd 1
- The Wellcome Trust 1
- U.S. Department of Health and Human Services (HHS) 1
- UCB GmbH 1
- UCB S.A. 1
- University of Cambridge 1
- University of Leicester 1
- University of Manchester 1
- University of Pennsylvania 1
- Vanda Pharmaceuticals 1
- WILEY-VCH GmbH 1
- Zentralinstitut für Seelische Gesundheit 1
- deCODE genetics 1